These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28439165)

  • 1. Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study.
    Majumdar SK; Krishna S; Chatterjee A; Chakraborty R; Ansari N
    J Maxillofac Oral Surg; 2017 Jun; 16(2):226-230. PubMed ID: 28439165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study.
    Dasukil S; Shetty SK; Arora G; Degala S
    J Maxillofac Oral Surg; 2021 Mar; 20(1):115-120. PubMed ID: 33584052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Efficacy of Different Concentrations of Dextrose Prolotherapy in Temporomandibular Joint Hypermobility Treatment.
    Mustafa R; Güngörmüş M; Mollaoğlu N
    J Craniofac Surg; 2018 Jul; 29(5):e461-e465. PubMed ID: 29533255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years' follow up.
    Refai H
    Br J Oral Maxillofac Surg; 2017 Jun; 55(5):465-470. PubMed ID: 28460873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta-analysis.
    Nagori SA; Jose A; Gopalakrishnan V; Roy ID; Chattopadhyay PK; Roychoudhury A
    J Oral Rehabil; 2018 Dec; 45(12):998-1006. PubMed ID: 30024045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial.
    Cömert Kiliç S; Kiliç N; Güngörmüş M
    J Oral Maxillofac Surg; 2023 Apr; 81(4):389-395. PubMed ID: 36693543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Autologous Blood Injection and Dextrose Prolotherapy in the Treatment of Chronic Recurrent Temporomandibular Dislocation: A Randomized Clinical Trial.
    Chhapane A; Wadde K; Sachdev SS; Barai S; Landge J; Wadewale M
    J Maxillofac Oral Surg; 2024 Apr; 23(2):278-284. PubMed ID: 38601242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults.
    Zhou H; Xue Y; Liu P
    Head Face Med; 2021 Mar; 17(1):11. PubMed ID: 33773589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility.
    Taşkesen F; Cezairli B
    Cranio; 2023 Sep; 41(5):423-431. PubMed ID: 33326351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial.
    Refai H; Altahhan O; Elsharkawy R
    J Oral Maxillofac Surg; 2011 Dec; 69(12):2962-70. PubMed ID: 21757278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial.
    Cömert Kiliç S; Güngörmüş M
    Int J Oral Maxillofac Surg; 2016 Jul; 45(7):813-9. PubMed ID: 26846795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study.
    Pandey SK; Baidya M; Srivastava A; Garg H
    Natl J Maxillofac Surg; 2022; 13(3):398-404. PubMed ID: 36683930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation.
    Zhou H; Hu K; Ding Y
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):63-6. PubMed ID: 24064304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of Combined, Single-Session Arthrocentesis and Dextrose Prolotherapy for Symptomatic Temporomandibular Joint Syndrome: A Case Series.
    Cezairli B; Sivrikaya EC; Omezli MM; Ayranci F; Seyhan Cezairli N
    J Altern Complement Med; 2017 Oct; 23(10):771-777. PubMed ID: 29017019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparative Preliminary Randomized Clinical Study to Evaluate Heavy Bupivacaine Dextrose Prolotherapy (HDP) and Autologous Blood Injection (ABI) for Symptomatic Temporomandibular Joint Hypermobility Disorder.
    Bhargava D; Sivakumar B; Bhargava PG
    J Maxillofac Oral Surg; 2023 Mar; 22(1):110-118. PubMed ID: 36703672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of temporomandibular joint luxation: a systematic literature review.
    Abrahamsson H; Eriksson L; Abrahamsson P; Häggman-Henrikson B
    Clin Oral Investig; 2020 Jan; 24(1):61-70. PubMed ID: 31729577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: A randomized, double-blind clinical study.
    Haggag MA; Al-Belasy FA; Said Ahmed WM
    J Craniomaxillofac Surg; 2022 May; 50(5):426-431. PubMed ID: 35501215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of prolotherapy on condyles in temporomandibular joint hypermobility using fractal dimension analysis.
    Memiş S
    J Korean Assoc Oral Maxillofac Surg; 2022 Feb; 48(1):33-40. PubMed ID: 35221305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of autologous conditioned serum versus dextrose prolotherapy in internal derangement of the TMJ - A pilot study.
    Ravikumar C; Sasikala B; Krishnakumar Raja VB; Elavenil P
    J Craniomaxillofac Surg; 2024 Apr; 52(4):477-483. PubMed ID: 38368212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term results of prolotherapy in the management of temporomandibular joint dislocation.
    Ungor C; Atasoy KT; Taskesen F; Cezairli B; Dayisoylu EH; Tosun E; Senel FC
    J Craniofac Surg; 2013 Mar; 24(2):411-5. PubMed ID: 23524704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.